Lucid Announces Third Quarter 2026 Results, Reduces Cash Consumption by 30%, Transformation on Track, Liquidity increased by $1.75 billion
- Reduced quarterly cash consumption by 30% sequentially; further improvements remain a strategic imperative.
- Material progress on each of the company's four Must-Win priorities.
- Transformation advancing with investment in leadership, customer experience, strategic programs, brand revamp and foundations for profitable growth.
- Liquidity increased by
$1.75 billion through expanded support from the PIF.
"Our transformation is beginning to show progress. We are acting with urgency, strengthening the fundamentals and driving greater discipline, while continuing to invest in the priorities to deliver profitable long-term growth," said
"The operating reset announced with our Q2 results includes decisive actions to align our manufacturing capacity with demand, reduce inventory and lower operating expenses. These actions are already showing through in Q3, with free cash flow consumption 30% lower sequentially," said
As shared at Q2, Lucid expects to communicate its mid-term plan and targets early next year.
Delivering on Key Priorities
During Q3, the company advanced each of its four Must-Win priorities. These represent Lucid's framework for transforming its business and measuring progress:
$1.4 Billion Cash Flow Improvement Plan: year to date, Lucid has achieved savings of$0.8 billion and implemented additional actions to drive continued improvement. The company remains on track to achieve its full-year target.- Autonomy & Robotaxi: Lucid achieved all of the project milestones scheduled by the end of Q3 in the partnership with Uber and Nuro. In August, the program expanded to more than 100 vehicles on the road. Lucid also announced a partnership with Bolt, one of
Europe's leading mobility platforms, with an initial goal of deploying at least 25,000 vehicles. - Advanced Manufacturing Plant 2: construction of Lucid's AMP-2 manufacturing facility in
Saudi Arabia is progressing to plan and has entered the final stages of industrialization and commissioning. Inauguration is expected in early 2027. - Midsize: testing, final-stage prototyping and validation continued during Q3, with pilot production entering the final phase. Production remains planned for the second half of 2027. Lucid expects to announce reveal and production dates in the first quarter of 2027.
Third Quarter 2026 Performance
Lucid reported third quarter revenue of
1 S&P Mobility: Light Vehicle Sales Forecast,
Conference Call Information
Lucid will host a conference call to discuss its third quarter 2026 financial results on
About
Investor Relations Contact
Media Contact
Trademarks
This communication contains trademarks, service marks, trade names and copyrights of Lucid Group, Inc. and its subsidiaries and other companies, which are the property of their respective owners.
Forward-Looking Statements
This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "shall," "expect," "anticipate," "believe," "seek," "target," "continue," "could," "may," "might," "possible," "potential," "predict," "scheduled," "aiming," "targeting," "objective," "focus," "strategic" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding results of operations, financial outlook and condition, guidance, liquidity, capital expenditures, strategic priorities, cash flow improvement plan and cash consumption, prospects, growth, production volumes, strategies, management, and the markets in which Lucid operates, including expectations of financial and operational metrics, projections of market opportunity, market share and product sales, expectations and timing related to commercial product launches and future programs, initiatives and products, including the Midsize program, plans and expectations on vehicle production and delivery timing and volumes, expectations regarding market opportunities and demand for Lucid's products, software, strategic partnership, technology features and capabilities, including with respect to battery and powertrain systems, plans and expectations regarding Lucid's liquidity runway, future capital raises and funding strategy, plans and expectations regarding future manufacturing capabilities and facilities, logistics and supply chain, studio and service center openings, sales channels and strategies, future market launches and international expansion, Lucid's ability to grow its brand awareness, the potential success of Lucid's distribution strategy and future vehicle programs, potential automotive and strategic partnerships and their anticipated benefits, plans and expectations regarding Lucid's ADAS/AV roadmap and robotaxi program, expectations on the technology licensing landscape, expectations on the regulatory and political environment, and expectation regarding the potential of Lucid's technology. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Lucid's management. These forward-looking statements are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from these forward-looking statements. Many actual events and circumstances are beyond the control of Lucid. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, economic, market, financial, political, regulatory and legal conditions, including uncertainties and changes of policies, imposition or proposed imposition of tariffs, export controls, threat of a trade war, the risk of a global economic recession or other downturn, bank closures and liquidity concerns at financial institutions, and global or regional conflicts or other geopolitical events, including the ongoing military operations in the Gulf region and the broader
Non-GAAP Financial Measures and Key Business Metrics
Condensed consolidated financial information has been presented in accordance with US GAAP ("GAAP") as well as on a non-GAAP basis to supplement Lucid's condensed consolidated financial results. Lucid's non-GAAP financial measures include Adjusted EBITDA, adjusted net loss attributable to common stockholders (diluted), adjusted net loss per share attributable to common stockholders (diluted), and free cash flow, which are discussed below.
Adjusted EBITDA is defined as net loss attributable to common stockholders (basic) before (1) interest expense, (2) interest income, (3) provision for (benefit from) income taxes, (4) depreciation and amortization, (5) stock-based compensation, (6) workforce reduction charges, (7) change in fair value of common stock warrant liability, (8) change in fair value of equity securities of a related party, (9) change in fair value of derivative liabilities and subscription agreements associated with redeemable convertible preferred stock (related party), (10) accretion of redeemable convertible preferred stock (related party), and (11) gain on extinguishment of debt. Lucid believes that Adjusted EBITDA provides useful information to Lucid's management and investors about Lucid's financial performance.
Adjusted net loss attributable to common stockholders (diluted) is defined as net loss attributable to common stockholders (diluted) excluding (1) stock-based compensation, (2) workforce reduction charges, (3) change in fair value of common stock warrant liability, (4) change in fair value of equity securities of a related party, (5) change in fair value of derivative liabilities and subscription agreements associated with redeemable convertible preferred stock (related party), and (6) accretion of redeemable convertible preferred stock (related party).
Lucid defines and calculates adjusted net loss per share attributable to common stockholders (diluted) as adjusted net loss attributable to common stockholders (diluted) divided by weighted-average shares outstanding attributable to common stockholders (diluted).
Lucid believes that adjusted net loss attributable to common stockholders (diluted) and adjusted net loss per share attributable to common stockholders (diluted) financial measures provide investors with useful information to evaluate the performance of its business excluding items not reflecting ongoing operating activities.
Free cash flow is defined as net cash used in operating activities less capital expenditures. Lucid believes that free cash flow provides useful information to Lucid's management and investors about the amount of cash generated by the business after necessary capital expenditures.
These non-GAAP financial measures facilitate management's internal comparisons to Lucid's historical performance. Management believes that it is useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting, and financial planning purposes. Management also believes that presentation of the non-GAAP financial measures provides useful information to Lucid's investors regarding measures of its financial condition and results of operations that Lucid uses to run the business and therefore allows investors to better understand Lucid's performance. However, these non-GAAP financial and key performance measures have limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of Lucid's results as reported under GAAP.
Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under GAAP when understanding Lucid's operating performance. In addition, other companies, including companies in Lucid's industry, may calculate non-GAAP financial measures and key performance measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of Lucid's non-GAAP financial measures and key performance measures as tools for comparison. A reconciliation between GAAP and non-GAAP financial information is presented below.
|
|
||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||
|
(Unaudited) |
||||
|
(in thousands, except share and per share data) |
||||
|
|
||||
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
|
$ 930,742 |
|
$ 997,827 |
|
Short-term investments (including nil and |
|
4,787 |
|
631,093 |
|
Accounts receivable, net (including |
|
199,346 |
|
177,162 |
|
Inventory |
|
1,222,492 |
|
1,109,529 |
|
Prepaid expenses |
|
60,131 |
|
59,606 |
|
Other current assets |
|
342,300 |
|
324,434 |
|
Total current assets |
|
2,759,798 |
|
3,299,651 |
|
Property, plant and equipment, net |
|
4,374,861 |
|
3,978,132 |
|
Right-of-use assets |
|
243,925 |
|
241,974 |
|
Long-term investments (including |
|
12,973 |
|
512,241 |
|
Other noncurrent assets |
|
419,234 |
|
354,983 |
|
TOTAL ASSETS |
|
$ 7,810,791 |
|
$ 8,386,981 |
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Accounts payable |
|
$ 241,099 |
|
$ 487,521 |
|
Finance lease liabilities, current portion |
|
5,054 |
|
84,222 |
|
Current portion of debt ( |
|
707,545 |
|
671,746 |
|
Other current liabilities (including |
|
1,232,717 |
|
1,392,641 |
|
Total current liabilities |
|
2,186,415 |
|
2,636,130 |
|
Finance lease liabilities, net of current portion |
|
101,518 |
|
104,559 |
|
Debt, net of current portion (including |
|
3,741,353 |
|
2,046,576 |
|
Other long-term liabilities (including |
|
671,858 |
|
582,739 |
|
Derivative liabilities associated with redeemable convertible preferred stock (related party) |
|
48,479 |
|
16,200 |
|
Total liabilities |
|
6,749,623 |
|
5,386,204 |
|
|
|
|
|
|
|
REDEEMABLE CONVERTIBLE PREFERRED STOCK |
|
|
|
|
|
Preferred stock 10,000,000 shares authorized as of |
|
1,534,739 |
|
1,339,641 |
|
Preferred stock 10,000,000 shares authorized as of |
|
1,078,032 |
|
943,849 |
|
Preferred stock 10,000,000 shares authorized as of |
|
543,397 |
|
— |
|
Total redeemable convertible preferred stock |
|
3,156,168 |
|
2,283,490 |
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (DEFICIT) |
|
|
|
|
|
Common stock, par value |
|
40 |
|
33 |
|
Additional paid-in capital |
|
16,428,919 |
|
16,337,023 |
|
|
|
(20,716) |
|
(20,716) |
|
Accumulated other comprehensive income |
|
1,556 |
|
11,692 |
|
Accumulated deficit |
|
(18,504,799) |
|
(15,610,745) |
|
Total stockholders' equity (deficit) |
|
(2,095,000) |
|
717,287 |
|
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY |
|
$ 7,810,791 |
|
$ 8,386,981 |
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS |
|||||||
|
(Unaudited) |
|||||||
|
(in thousands, except share and per share data) |
|||||||
|
|
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Revenue (including |
$ 350,319 |
|
$ 336,580 |
|
$ 1,038,131 |
|
$ 831,060 |
|
|
|
|
|
|
|
|
|
|
Costs and expenses |
|
|
|
|
|
|
|
|
Cost of revenue |
608,624 |
|
670,197 |
|
2,034,866 |
|
1,665,540 |
|
Research and development |
311,821 |
|
325,305 |
|
968,827 |
|
850,390 |
|
Selling, general and administrative |
286,191 |
|
283,097 |
|
890,799 |
|
752,129 |
|
Workforce reduction charges |
1,270 |
|
— |
|
72,879 |
|
— |
|
Total cost and expenses |
1,207,906 |
|
1,278,599 |
|
3,967,371 |
|
3,268,059 |
|
|
|
|
|
|
|
|
|
|
Loss from operations |
(857,587) |
|
(942,019) |
|
(2,929,240) |
|
(2,436,999) |
|
|
|
|
|
|
|
|
|
|
Other income (expense), net |
|
|
|
|
|
|
|
|
Change in fair value of common stock warrant liability |
— |
|
444 |
|
— |
|
18,627 |
|
Change in fair value of equity securities of a related party |
(1,226) |
|
916 |
|
(10,898) |
|
(8,589) |
|
Change in fair value of derivative liabilities and subscription agreements associated |
115,176 |
|
(36,375) |
|
225,341 |
|
356,800 |
|
Gain on extinguishment of debt |
— |
|
— |
|
— |
|
116,360 |
|
Interest income |
11,420 |
|
34,643 |
|
34,158 |
|
131,170 |
|
Interest expense (including |
(69,871) |
|
(25,571) |
|
(158,761) |
|
(61,203) |
|
Other expense, net |
(29,063) |
|
(10,829) |
|
(53,719) |
|
(4,292) |
|
Total other income (expense), net |
26,436 |
|
(36,772) |
|
36,121 |
|
548,873 |
|
Loss before provision for (benefit from) income taxes |
(831,151) |
|
(978,791) |
|
(2,893,119) |
|
(1,888,126) |
|
Provision for (benefit from) income taxes |
(292) |
|
(363) |
|
935 |
|
(4,095) |
|
Net loss |
(830,859) |
|
(978,428) |
|
(2,894,054) |
|
(1,884,031) |
|
Accretion of redeemable convertible preferred stock (related party) |
(249,911) |
|
(56,121) |
|
(580,298) |
|
(620,869) |
|
Net loss attributable to common stockholders, basic |
(1,080,770) |
|
(1,034,549) |
|
(3,474,352) |
|
(2,504,900) |
|
Interest expense on 2026 Notes |
— |
|
— |
|
— |
|
4,283 |
|
Gain on extinguishment of debt |
— |
|
— |
|
— |
|
(116,360) |
|
Net loss attributable to common stockholders, diluted |
$ (1,080,770) |
|
$ (1,034,549) |
|
$ (3,474,352) |
|
$ (2,616,977) |
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding attributable to common stockholders |
|
|
|
|
|
|
|
|
Basic |
394,598,004 |
|
312,166,297 |
|
368,570,326 |
|
307,177,163 |
|
Diluted |
394,598,004 |
|
312,166,297 |
|
368,570,326 |
|
307,859,815 |
|
|
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
Basic |
$ (2.74) |
|
$ (3.31) |
|
$ (9.43) |
|
$ (8.15) |
|
Diluted |
$ (2.74) |
|
$ (3.31) |
|
$ (9.43) |
|
$ (8.50) |
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
Net unrealized gains (losses) on investments, net of tax |
$ 121 |
|
$ 684 |
|
$ (1,416) |
|
$ 4,529 |
|
Reclassification adjustment for realized gains on investments included in net loss |
— |
|
— |
|
(5,702) |
|
— |
|
Foreign currency translation adjustments |
820 |
|
(2,187) |
|
(3,018) |
|
10,683 |
|
Total other comprehensive income (loss) |
941 |
|
(1,503) |
|
(10,136) |
|
15,212 |
|
Comprehensive loss |
(829,918) |
|
(979,931) |
|
(2,904,190) |
|
(1,868,819) |
|
Accretion of redeemable convertible preferred stock (related party) |
(249,911) |
|
(56,121) |
|
(580,298) |
|
(620,869) |
|
Comprehensive loss attributable to common stockholders |
$ (1,079,829) |
|
$ (1,036,052) |
|
$ (3,484,488) |
|
$ (2,489,688) |
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
(Unaudited) |
|||||||
|
(in thousands) |
|||||||
|
|
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
$ (830,859) |
|
$ (978,428) |
|
$ (2,894,054) |
|
$ (1,884,031) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
122,529 |
|
120,090 |
|
361,163 |
|
329,137 |
|
Amortization of insurance premium |
10,078 |
|
9,536 |
|
29,365 |
|
27,021 |
|
Non-cash operating lease cost |
18,285 |
|
12,928 |
|
51,482 |
|
32,686 |
|
Stock-based compensation |
36,578 |
|
115,055 |
|
144,217 |
|
198,889 |
|
Inventory and firm purchase commitments write-downs |
93,734 |
|
190,664 |
|
621,322 |
|
518,470 |
|
Change in fair value of common stock warrant liability |
— |
|
(444) |
|
— |
|
(18,627) |
|
Change in fair value of equity securities of a related party |
1,226 |
|
(916) |
|
10,898 |
|
8,589 |
|
Change in fair value of derivative liabilities and subscription agreements associated |
(115,176) |
|
36,375 |
|
(225,341) |
|
(356,800) |
|
Net accretion of investment discounts/premiums |
(84) |
|
(2,616) |
|
(1,174) |
|
(21,678) |
|
Gain on extinguishment of debt |
— |
|
— |
|
— |
|
(116,360) |
|
Other non-cash items |
21,121 |
|
719 |
|
23,261 |
|
10,019 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable (including |
25,739 |
|
(13,263) |
|
(22,530) |
|
(26,523) |
|
Inventory |
77,167 |
|
(446,557) |
|
(768,387) |
|
(1,032,600) |
|
Prepaid expenses |
2,241 |
|
(4,366) |
|
(28,431) |
|
(32,043) |
|
Other assets |
(21,128) |
|
(76,962) |
|
(103,418) |
|
(132,786) |
|
Accounts payable |
(147,067) |
|
185,815 |
|
(285,432) |
|
244,328 |
|
Other liabilities (including |
(47,027) |
|
95,720 |
|
(73,474) |
|
236,805 |
|
Net cash used in operating activities |
(752,643) |
|
(756,650) |
|
(3,160,533) |
|
(2,015,504) |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment (including |
(287,071) |
|
(198,818) |
|
(794,065) |
|
(542,722) |
|
Proceeds from maturities of investments (including nil and |
24,000 |
|
451,968 |
|
201,228 |
|
2,413,453 |
|
Proceeds from sale of investments |
— |
|
— |
|
951,125 |
|
— |
|
Purchases of investments (including nil from a related party for the three months |
(59) |
|
— |
|
(28,571) |
|
(309,557) |
|
Other investing activities |
— |
|
1,968 |
|
— |
|
1,968 |
|
Net cash provided by (used in) investing activities |
(263,130) |
|
255,118 |
|
329,717 |
|
1,563,142 |
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - continued (Unaudited) (in thousands) |
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock under the 2026 Underwriting |
— |
|
— |
|
292,500 |
|
— |
|
Payments of issuance costs for the 2026 Underwriting Agreement |
(387) |
|
— |
|
(966) |
|
— |
|
Proceeds from issuance of common stock under the 2026 Subscription |
— |
|
— |
|
200,000 |
|
— |
|
Payments of issuance costs for the 2026 Subscription Agreement |
(156) |
|
— |
|
(156) |
|
— |
|
Proceeds from issuance of common stock under the 2025 Subscription |
— |
|
300,000 |
|
— |
|
300,000 |
|
Payment of issuance costs for the 2025 Subscription Agreement |
— |
|
(278) |
|
— |
|
(278) |
|
Proceeds from issuance of Series C redeemable convertible preferred stock to a |
— |
|
— |
|
550,000 |
|
— |
|
Payments of issuance costs for Series C redeemable convertible preferred stock |
(400) |
|
— |
|
(1,150) |
|
— |
|
Payments of transaction costs for the issuance of 2031 Notes |
— |
|
— |
|
(1,165) |
|
— |
|
Proceeds from issuance of 2030 Notes |
— |
|
— |
|
— |
|
1,100,000 |
|
Payments of transaction costs for the issuance of 2030 Notes |
— |
|
(166) |
|
— |
|
(18,090) |
|
Purchase of capped call options |
— |
|
— |
|
— |
|
(118,250) |
|
Repurchase of 2026 Notes |
— |
|
— |
|
— |
|
(931,433) |
|
Proceeds from borrowings from related parties |
1,200,000 |
|
79,976 |
|
1,735,994 |
|
186,621 |
|
Proceeds from exercise of stock options |
— |
|
626 |
|
2,785 |
|
1,900 |
|
Proceeds from employee stock purchase plan |
— |
|
— |
|
9,833 |
|
12,696 |
|
Tax withholding payments for net settlement of employee awards |
(27) |
|
(3,060) |
|
(1,338) |
|
(12,509) |
|
Payment for finance lease liabilities |
(1,255) |
|
(1,046) |
|
(3,716) |
|
(2,422) |
|
Payments for credit facility issuance costs to related parties |
— |
|
— |
|
(3,750) |
|
(507) |
|
Net cash provided by financing activities |
1,197,775 |
|
376,052 |
|
2,778,871 |
|
517,728 |
|
Net increase (decrease) in cash, cash equivalents, and restricted cash |
182,002 |
|
(125,480) |
|
(51,945) |
|
65,366 |
|
Beginning cash, cash equivalents, and restricted cash |
806,966 |
|
1,797,898 |
|
1,040,913 |
|
1,607,052 |
|
Ending cash, cash equivalents, and restricted cash |
$ 988,968 |
|
$ 1,672,418 |
|
$ 988,968 |
|
$ 1,672,418 |
|
|
|||||||
|
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
|||||||
|
(Unaudited) |
|||||||
|
(in thousands, except share and per share data) |
|||||||
|
|
|||||||
|
Adjusted EBITDA |
|||||||
|
|
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Net loss attributable to common stockholders, basic (GAAP) |
$ (1,080,770) |
|
$ (1,034,549) |
|
$ (3,474,352) |
|
$ (2,504,900) |
|
Interest expense |
69,871 |
|
25,571 |
|
158,761 |
|
61,203 |
|
Interest income |
(11,420) |
|
(34,643) |
|
(34,158) |
|
(131,170) |
|
Provision for (benefit from) income taxes |
(292) |
|
(363) |
|
935 |
|
(4,095) |
|
Depreciation and amortization |
122,529 |
|
120,090 |
|
361,163 |
|
329,137 |
|
Stock-based compensation |
36,578 |
|
115,055 |
|
140,915 |
|
198,889 |
|
Workforce reduction charges |
1,270 |
|
— |
|
72,879 |
|
— |
|
Change in fair value of common stock warrant liability |
— |
|
(444) |
|
— |
|
(18,627) |
|
Change in fair value of equity securities of a related party |
1,226 |
|
(916) |
|
10,898 |
|
8,589 |
|
Change in fair value of derivative liabilities and subscription agreements |
(115,176) |
|
36,375 |
|
(225,341) |
|
(356,800) |
|
Accretion of redeemable convertible preferred stock (related party) |
249,911 |
|
56,121 |
|
580,298 |
|
620,869 |
|
Gain on extinguishment of debt |
— |
|
— |
|
— |
|
(116,360) |
|
Adjusted EBITDA (non-GAAP) |
$ (726,273) |
|
$ (717,703) |
|
$ (2,408,002) |
|
$ (1,913,265) |
|
|
|||||||
|
Adjusted Net Loss Attributable to Common Stockholders |
|||||||
|
|
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Net loss attributable to common stockholders, diluted (GAAP) |
$ (1,080,770) |
|
$ (1,034,549) |
|
$ (3,474,352) |
|
$ (2,616,977) |
|
Stock-based compensation |
36,578 |
|
115,055 |
|
140,915 |
|
198,889 |
|
Workforce reduction charges |
1,270 |
|
— |
|
72,879 |
|
— |
|
Change in fair value of common stock warrant liability |
— |
|
(444) |
|
— |
|
(18,627) |
|
Change in fair value of equity securities of a related party |
1,226 |
|
(916) |
|
10,898 |
|
8,589 |
|
Change in fair value of derivative liabilities and subscription agreements |
(115,176) |
|
36,375 |
|
(225,341) |
|
(356,800) |
|
Accretion of redeemable convertible preferred stock (related party) |
249,911 |
|
56,121 |
|
580,298 |
|
620,869 |
|
Adjusted net loss attributable to common stockholders, diluted (non-GAAP) |
$ (906,961) |
|
$ (828,358) |
|
$ (2,894,703) |
|
$ (2,164,057) |
|
|
|||||||
|
Adjusted Net Loss Per Share Attributable to Common Stockholders |
|||||||
|
|
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Net loss per share attributable to common stockholders, diluted (GAAP) |
$ (2.74) |
|
$ (3.31) |
|
$ (9.43) |
|
$ (8.50) |
|
Stock-based compensation |
0.09 |
|
0.37 |
|
0.38 |
|
0.65 |
|
Workforce reduction charges |
— |
|
— |
|
0.20 |
|
— |
|
Change in fair value of common stock warrant liability |
— |
|
— |
|
— |
|
(0.06) |
|
Change in fair value of equity securities of a related party |
— |
|
— |
|
0.03 |
|
0.03 |
|
Change in fair value of derivative liabilities and subscription agreements |
(0.29) |
|
0.11 |
|
(0.61) |
|
(1.17) |
|
Accretion of redeemable convertible preferred stock (related party) |
0.64 |
|
0.18 |
|
1.58 |
|
2.02 |
|
Adjusted net loss per share attributable to common stockholders, diluted |
$ (2.30) |
|
$ (2.65) |
|
$ (7.85) |
|
$ (7.03) |
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding attributable to common stockholders, |
394,598,004 |
|
312,166,297 |
|
368,570,326 |
|
307,859,815 |
|
|
|||||||
|
|
|||||||
|
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - continued |
|||||||
|
(Unaudited) |
|||||||
|
(in thousands) |
|||||||
|
|
|||||||
|
Free Cash Flow |
|||||||
|
|
|||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
Net cash used in operating activities (GAAP) |
$ (752,643) |
|
$ (756,650) |
|
$ (3,160,533) |
|
$ (2,015,504) |
|
Capital expenditures |
(287,071) |
|
(198,818) |
|
(794,065) |
|
(542,722) |
|
Free cash flow (non-GAAP) |
$ (1,039,714) |
|
$ (955,468) |
|
$ (3,954,598) |
|
$ (2,558,226) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-announces-third-quarter-2026-results-reduces-cash-consumption-by-30-transformation-on-track-liquidity-increased-by-1-75-billion-302933812.html
SOURCE